Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data.

Lambert J, Di Blasi R, Rabian F, Dourthe ME, Baruchel A, Thiéblemont C, Boissel N, Levy V, Picat MQ, Chevret S

DOI: 10.1097/hs9.0000000000000873
Published: 2023 Jun
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/hs9.0000000000000873,
  title = {Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data.},
  author = {Lambert J and Di Blasi R and Rabian F and Dourthe ME and Baruchel A and Thiéblemont C and Boissel N and Levy V and Picat MQ and Chevret S},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/hs9.0000000000000873},
  url = {https://doi.org/10.1097/hs9.0000000000000873}
}

RIS

TY  - JOUR
TI  - Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data.
AU  - Lambert J
AU  - Di Blasi R
AU  - Rabian F
AU  - Dourthe ME
AU  - Baruchel A
AU  - Thiéblemont C
AU  - Boissel N
AU  - Levy V
AU  - Picat MQ
AU  - Chevret S
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/hs9.0000000000000873
UR  - https://doi.org/10.1097/hs9.0000000000000873
ER  -

APA

J, L., R, D. B., F, R., ME, D., A, B., C, T., N, B., V, L., MQ, P., & S, C. (2023). Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data.. HemaSphere. https://doi.org/10.1097/hs9.0000000000000873

Source records

pubmed · retrieved 2026-09-26T05:36:46.515Z